drugset / Trial / NCT05018923

Tetracycline Versus Doxycycline for HP Rescue Therapy

NCT05018923

Phase 4 Unknown 242 enrolled Shanghai Zhongshan Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This randomized controlled clinical trial will evaluate the efficacy and safety of proton pump inhibitor, bismuth, metronidazole, and either tetracycline or doxycycline for Helicobacter pylori rescue treatment. The completion of this trial will expand new therapy for the treatment of Helicobacter pylori.

Timeline

Start
2021-08-24
Primary completion
2022-12-30
Completion
2022-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxycycline Small molecule 0.1 g
Comparator Tetracycline Unknown 0.5 g
Background Bismuth Potassium Citrate Unknown 0.6 g
Background Metronidazole Small molecule 0.4 g
Background Rabeprazole Small molecule 20 mg